• Dual Luciferase Reporter Gene System for BMSCs

  2026-08-11

  Learn how a Dual Luciferase Reporter Gene System can convert lncRNA–pathway hypotheses into quantitative regulatory evidence in BMSCs. This article connects the MRF–FSHR–cAMP–PKA–CREB findings of a 2025 study with practical reporter design, normalization, controls, and interpretation.

• Dual Luciferase Reporter Gene System for Causal Mapping

  2026-08-11

  Learn how the Dual Luciferase Reporter Gene System can convert complex transcriptional networks into quantitative, internally normalized measurements. Using the MYC2–LBD40/42–CRL3BPM4 module as a design case, this article presents a causal framework for reporter selection, controls, and assay interpretation.

• GM 6001 for ECM and MMP Research

  2026-08-10

  GM 6001, also called Galardin, provides a nanomolar tool for testing how MMP-driven extracellular matrix remodeling affects tissue repair, signaling, cancer phenotypes, and neural perineuronal nets. This guide combines practical dosing, controls, troubleshooting, and a reference-study-informed workflow for separating matrix protection from downstream pathway effects.

• H-Aggregated IR-1061 for NIR-II Cancer Therapy

  2026-08-09

  Yu et al. developed RRIALP-C4, an RR9-functionalized anionic liposome that carries IR-1061 and carboplatin while transferring the fluorophore’s H-aggregated state to tumor cell membranes. The resulting formulation combines NIR-II fluorescence imaging, photothermal therapy, and temperature-sensitive chemotherapy release, providing a mechanistically informed strategy for image-guided cancer treatment.

• Cy5 amine (non-sulfonated): Labeling Guide

  2026-08-08

  Cy5 amine (non-sulfonated) is a primary-amine cyanine reagent for covalent labeling of suitably activated proteins, peptides, polymers, and other biomolecules. It is water-insoluble, so it should be dissolved in an organic co-solvent before aqueous coupling and should not be used for direct aqueous labeling or diagnostic applications.

• Epalrestat Workflows for Oxidative Stress Research

  2026-08-07

  Epalrestat combines aldose reductase inhibition with a research opportunity to investigate KEAP1/Nrf2-linked neuroprotection. This practical guide covers formulation, cell and animal workflows, Parkinson’s disease models, diabetic neuropathy research, and troubleshooting for reproducible oxidative stress studies.

• Concanamycin A: V-type H+-ATPase Inhibitor Workflows in Canc

  2026-08-07

  Concanamycin A delivers nanomolar potency and selectivity as a V-type H+-ATPase inhibitor, enabling precise modulation of endosomal acidification and apoptosis pathways in cancer models. This article unpacks applied protocols, troubleshooting strategies, and new avenues for integrating ceramide signaling insights, maximizing the translational impact of APExBIO's Concanamycin A.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Precision in Immuno

  2026-08-06

  The FITC Goat Anti-Mouse IgG (H+L) Antibody empowers researchers with high-sensitivity fluorescent detection of mouse IgG in immunofluorescence and flow cytometry. Its robust signal amplification and workflow flexibility enable reproducible, quantitative results for even the most challenging cell biology and immunology experiments.

• GPR35-KLF5 Circuitry Orchestrates Epithelial Repair in Colit

  2026-08-06

  The referenced study uncovers a tryptophan metabolism–dependent gatekeeper mechanism in which GPR35 senses mucosal damage and initiates KLF5-driven repair programming in intestinal epithelial cells. This mechanistic insight clarifies how metabolic cues are decoded into reparative responses, with significant implications for modeling and treating ulcerative colitis.

• Dual OXPHOS Disruption: LRPPRC Inhibition and Dasatinib Syne

  2026-08-05

  This study identifies a novel combination strategy in cancer therapy by pairing LRPPRC inhibition with dasatinib to achieve synergistic disruption of mitochondrial oxidative phosphorylation (OXPHOS). By targeting both mitochondrial and nuclear OXPHOS gene expression, this approach offers a promising, mechanistically rational pathway for treating OXPHOS-dependent tumors.

• (-)-Arctigenin: Mechanistic Depth and Translational Potentia

  2026-08-05

  Explore the multifaceted mechanisms of (-)-Arctigenin as a MEK1 inhibitor and iNOS expression modulator. This article provides an advanced scientific perspective on its role in NF-κB-driven breast cancer progression and translational assay design.

• ω-Agatoxin IVA TFA: Precision Cav2.1 Blockade in Epilepsy Mo

  2026-08-04

  Explore the advanced neuropharmacology of ω-Agatoxin IVA TFA, a highly selective P/Q-type calcium channel blocker, and its applications in epilepsy animal models and synaptic research. This article provides a unique, translational perspective linking channel selectivity to neuroprotection strategies.

• Cell Line and Reporter Gene Impact on mRNA-LNP Transfection

  2026-08-04

  Zhen et al. systematically evaluate how cell line and reporter gene selection affect in vitro transfection efficiency and reproducibility for mRNA lipid nanoparticles (mRNA-LNPs). Their findings highlight the critical need to optimize both experimental parameters to accurately assess mRNA delivery, with significant implications for translation efficiency assays and the development of mRNA therapeutics.

• Epalrestat: Aldose Reductase Inhibitor for Neuroprotection

  2026-08-03

  Epalrestat is a high-purity aldose reductase inhibitor with verified neuroprotective effects. It acts by inhibiting the polyol pathway and activating the KEAP1/Nrf2 signaling pathway, making it valuable for oxidative stress and diabetic neuropathy research. Recent evidence supports its utility in Parkinson’s disease models.

• N-octanoyl-L-Homoserine Lactone: Precision in Cancer-Microbe

  2026-08-03

  Explore how N-octanoyl-L-Homoserine lactone (C8-HSL) is revolutionizing cancer-microbiome research by enabling precision study of quorum sensing and host interactions. This article provides technical insights, unique protocol guidance, and critical analysis for advanced infection biology applications.

16452 records 1/1097 page Next 12345 下5页 Last page